@marstodeclan
I will answer truthfully on everything you have asked unlike others that actually ignore my questions and change the subject to their liking just to avoid what they don't know the answer to.\\The argument I am trying to put forward that RHY does not have a product that is "transformational", There are other companies world-wide that offer similar testing kits. Look at Guardant Health Shield for example. Let's not worry about the cost because they are expecting FDA approval any day now. Once this approved they will get Medicare/Medicaid to reimburse patients for the test.
This is one example. I don't believe it's a saturated market - as Glenn has stated with his interview with Alan Kohler paraphrased "there is plenty to go around.".
I do not believe there is anything fundamentally wrong with blood test kits. On the contrary. What I think is disappointing and not transparent are the levels of sensitivity and specificity at all stages of CRC including AA. Every other company worldwide that is DEVELOPING or has commercialised their product disclose this information. What is there to hide?
With regards to Governments (ie Australian Government) it has to go through the bureaucratic process just like the TGA approval process.
Has anyone thought that TGA is asking many questions back to RHY and each time they do the clock stops when trying to work out how many days it will take to get approval or not?
Yes, if the Australian Government adopts COLOSTAT then this the dream that may turn into reality. But again, before this happens, there will be further studies, analysis by third parties, medical practitioners, external scientists etc etc. The sensitivity and specificity of a product under more bigger samples tends to lower, this is why the big companies like GUARDANT and EXACT continue to spend tens and hundreds of millions of dollars in R&D. It's just not that simple. Marketing/selling is huge cost to a RHY partner or distributor. These guys need to make healthy margins.
Why are these other companies behind RHY with regard to their roadmaps? I don't understand this statement.
I am not aware of any TGA approved cheap test kit other than Colvera being a TGA approved manufacturer but FDA approved/registered. As most would be aware, COLVERA is for post surgery screen testing for the return of CRC in patients that have had a colonoscopy. It is not sold in Australia but is sold in the US. Not sure why it isn't sold in Australia.
Getting to market first? I believe RHY is very far away from competitors of blood-based test kits whether it be DNA or protein based.
The company that I have shown in a table in my previous post I believe will trump everyone. They say in the next few months but that's what everyone says. I don't want to disclose at this time as I am waiting for further information. The scientists behind this new product that actually has a name to it are world-renowned all over the globe. It's a serious company as is the CEO.
These are al my thoughts based on my own research. I hope I have answered all your questions. I can't be bothered proof-reading so if there are mistakes I apologise.
- Forums
- ASX - By Stock
- Ann: MST Access Financial Diagnostics Presentation
@marstodeclanI will answer truthfully on everything you have...
Featured News
Add RHY (ASX) to my watchlist
|
|||||
Last
6.2¢ |
Change
-0.002(3.13%) |
Mkt cap ! $15.41M |
Open | High | Low | Value | Volume |
6.9¢ | 6.9¢ | 6.2¢ | $9.837K | 157.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 49398 | 6.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
6.5¢ | 29999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 49398 | 0.062 |
1 | 133316 | 0.060 |
1 | 18000 | 0.056 |
2 | 19091 | 0.055 |
2 | 100000 | 0.050 |
Price($) | Vol. | No. |
---|---|---|
0.065 | 29999 | 1 |
0.067 | 260000 | 1 |
0.069 | 117678 | 1 |
0.070 | 1794 | 1 |
0.071 | 117305 | 2 |
Last trade - 13.01pm 26/08/2024 (20 minute delay) ? |
Featured News
RHY (ASX) Chart |